Membrane RANKL Target Cells

Part Numbers: J3381, J3385, J3362

customize-this-small

RANKLシグナルに影響を与えるバイオロジックスの作用機序評価

  • ICHガイドラインに準拠した事前認証
  • 96ウェルおよび384ウェルのプレートフォーマット
  • 初代細胞の培養が不要
  • 解凍してすぐに使える便利な ”Thaw and Use” または増殖可能な "Cell Propagation Model(CPM)" の2つフォーマットで提供

Choose a Product Format

Size

選択製品のカタログ番号: J3381

Please Enquire
This product is discontinued
This product is available under our Early Access program - Learn More
This product is available under our Catalog (FT) program - Learn More
Membrane RANKL Target Cells
Thaw-and-Use/1X each component
Your price:
Change Configuration

エフェクター機能と抗体結合親和性の測定

Receptor activator of nuclear factor κB (RANK/TRANCE receptor, TNFRSF11A) は、腫瘍壊死因子受容体 (TNFR) ファミリーの一員である。この受容体にリガンドである RANKL が結合すると、骨のモデリングやリモデリングにおける破骨細胞の形成、活性化、生存が制御されるほか、骨のターンオーバーの増加を特徴とするいくつかの病的な状態も制御しています。RANKLは、最初はII型膜貫通タンパク質(mRANKL)として産生され、プロテアーゼにより切断されて可溶性の RANKL となる。RANKL を標的とした抗体が mRANKL 発現細胞に結合すると、抗体依存性細胞媒介性細胞毒性(ADCC)や補体依存性細胞毒性(CDC)などのエフェクター機能が誘導され、mRANKL発現細胞が破壊されます。

mRANKL Target Cells は、遺伝子操作により、切断抵抗性の mRANKL を安定的に発現させた細胞株であり、mRANKL の表面発現を強化しています。mRANKL Target Cells は、抗RANKLブロッカーのADCCやCDCなどのエフェクター機能を測定するアッセイにおいて、標的細胞として使用できるように設計されています。また、mRANKLに対する抗体の結合親和性を測定するためにも使用することができます。

Assay Components

Membrane RANKL Target Cells are provided in thaw-and-use format (Cat.# J3381, J3385). These cryopreserved cells are ready to be thawed for use in assays that measure the effector functions of anti-RANKL blockers.

Membrane RANKL Target Cells are also available in Cell Propagation Model (CPM) format (Cat.# J3362). These cryopreserved cells can be thawed, propagated and banked for long-term use.

Workflow

Standard bioassay workflow with cultured cells
Improved bioassay workflow with thaw-and-use cells

Standardized Reagents Improve Results

  • Thaw-and-use format provides significant time and labor savings over traditional methods while reducing variability.
  • Easily amenable to high-throughput workflows.

Assay Principle

17870ma

mRANKL Target Cells used to measure ADCC with the ADCC Reporter Bioassay. Following engagement with the Fc region of a relevant antibody bound to a Target Cell, ADCC Bioassay Effector Cells expressing the FcγR will transduce intracellular signals, resulting in NFAT-mediated luciferase activity that can be easily quantified.

17871ma

mRANKL Target Cells used to measure CDC with the CytoTox-Glo™ Assay. The assay measures dead-cell protease activity, and the amount of luminescence directly correlates with the percentage of cells undergoing cytotoxic stress.

Assay Performance Data

Accuracy and precision are critical to bioassays and the development of biologics. This assay was developed and prequalified according to ICH guidelines for accuracy and precision, giving it the performance characteristics required for many applications of a bioassay used for antibody drug discovery research and development.

Accuracy: Measure of how close results are to a reference or "target" value.

IntraLab Precision: Measure of repeatability from multiple assays of the same homogeneous sample under the same operating conditions over a short time (same analyst; same lab; same day).

Intermediate Precision: Measure of repeatability of multiple assays of the same homogeneous sample with different analysts or equipment or on different days.

Linearity: Ability of the assay to provide measured values that are proportional to the concentration of the sample.

 

32454752-data-target-combined

The ADCC Reporter Bioassay using mRANKL Target Cells Shows Precision, Accuracy and Linearity.

Parameter Results
Accuracy % Expected Relative Potency % Recovery
50 46.0
70 68.9
100 100.3
150 144.9
200 214.7
Repeatability (% CV) 100% (Reference) 10.4
Intermediate Precision (% CV)   8.3
Linearity (r2)   0.9928
Linearity (y = mx + b)   y = 1.093x – 9.838

A 50–200% simulated potency series of denosumab-IgG1 was analyzed in triplicate in three independent experiments performed on three days by two analysts using mRANKL Target Cells in the ADCC Reporter Bioassay. Bio-Glo™ Reagent was added and luminescence quantified using the GloMax® Discover System. Data were analyzed and relative potencies calculated after parallelism determination using JMP® software. Data were generated using thaw-and-use cells.

 

17859ma

The ADCC Reporter Bioassay with mRANKL Target Cells measures the activity of the anti-RANKL antibody denosumab-IgG1. mRANKL Target Cells were added to a 96-well assay plate 18 hours prior to the assay. On the day of the assay, ADCC Effector Cells and a titration of denosumab-IgG1 were added. After a 24-hour induction at 37°C, Bio-Glo™ Luciferase Reagent was added and luminescence measured using the GloMax® Discover System. Data were fitted to a four-parameter logistic curve using GraphPad Prism® software. The EC50 was 69ng/ml for denosumab-IgG1 and fold induction was 10.2.

17860ma

A CDC assay measures the activity of the anti-RANKL antibody denosumab-IgG1. mRANKL Target Cells were added to a 96-well assay plate 18 hours prior to the assay. On the day of assay, 10% Normal Human Serum Complement and a titration of denosumab-IgG1 were added. After a 6-hour induction at 37°C, CytoTox-Glo™ Cytotoxicity Reagent was added and luminescence measured using the GloMax® Discover System. Data were fitted to a four-parameter logistic curve using GraphPad Prism® software. For denosumab-IgG1, the EC50 was 261ng/ml, fold induction was 11.0 and specific lysis was 53%.

製品仕様

You are viewing: J3381 Change Configuration

選択製品の構成品内容

Item Part # Size

Membrane RANKL Target Cells

J338A 1 × 0.5ml

分析証明書

Search by lot number

使用制限

Not For Medical Diagnostic Use.

保存条件

XX

Please see the Protocol for detailed storage conditions.

パテントおよび免責条項

NOT FOR MEDICAL DIAGNOSTIC USE. FOR IN VITRO USE ONLY. BY USE OF THIS PRODUCT, RECIPIENT AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE STATEMENT. If the recipient is not willing to accept the conditions of this limited use statement, and the product is unused, Promega will accept return of the unused product and provide the recipient with a full refund.

This product may not be further sold or transferred by the recipient and may be used only by the recipient, and then only for (1) research use; (2) discovery, development and monitoring of biologic drugs and vaccines; (3) quality assurance testing of biologic drugs and vaccines; and (4) product release assays for biologic drugs and vaccines. No other commercial use is allowed. “Commercial use” means any and all uses of this product by recipient for monetary or other consideration, including providing a service, information or data to unaffiliated third parties, and resale of this product for any use. Recipient has no right to propagate, modify, derivatize, genetically engineer or otherwise create variations of the cells or genes stably transfected within the cells. In addition, recipient must use luminescent assay reagents purchased from Promega for all luminescence-based assays using this product, or contact Promega to obtain a license for use of this product with reagents other than Promega’s. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING AS TO MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE WITH REGARDS TO THIS PRODUCT. The terms of this agreement shall be governed under the laws of the State of Wisconsin, USA.

製品仕様

You are viewing: J3385 Change Configuration

選択製品の構成品内容

Item Part # Size

Membrane RANKL Target Cells

J338A 5 × 0.5ml

分析証明書

Search by lot number

使用制限

Not For Medical Diagnostic Use.

保存条件

XX

Please see the Protocol for detailed storage conditions.

パテントおよび免責条項

NOT FOR MEDICAL DIAGNOSTIC USE. FOR IN VITRO USE ONLY. BY USE OF THIS PRODUCT, RECIPIENT AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE STATEMENT. If the recipient is not willing to accept the conditions of this limited use statement, and the product is unused, Promega will accept return of the unused product and provide the recipient with a full refund.

This product may not be further sold or transferred by the recipient and may be used only by the recipient, and then only for (1) research use; (2) discovery, development and monitoring of biologic drugs and vaccines; (3) quality assurance testing of biologic drugs and vaccines; and (4) product release assays for biologic drugs and vaccines. No other commercial use is allowed. “Commercial use” means any and all uses of this product by recipient for monetary or other consideration, including providing a service, information or data to unaffiliated third parties, and resale of this product for any use. Recipient has no right to propagate, modify, derivatize, genetically engineer or otherwise create variations of the cells or genes stably transfected within the cells. In addition, recipient must use luminescent assay reagents purchased from Promega for all luminescence-based assays using this product, or contact Promega to obtain a license for use of this product with reagents other than Promega’s. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING AS TO MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE WITH REGARDS TO THIS PRODUCT. The terms of this agreement shall be governed under the laws of the State of Wisconsin, USA.

製品仕様

You are viewing: J3362 Change Configuration

選択製品の構成品内容

Item Part # Size

Membrane RANKL Target Cells (CPM)

J336A 2 × 1ml

分析証明書

Search by lot number

使用制限

Not For Medical Diagnostic Use.

保存条件

XX

Please see the Protocol for detailed storage conditions.

パテントおよび免責条項

NOT FOR MEDICAL DIAGNOSTIC USE. FOR IN VITRO USE ONLY. BY USE OF THIS PRODUCT, RECIPIENT AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE STATEMENT. If the recipient is not willing to accept the conditions of this limited use statement, and the product is unused, Promega will accept return of the unused product and provide the recipient with a full refund.

This product may not be further sold or transferred by the recipient and may be used only by the recipient, and then only for (1) research use; (2) discovery, development and monitoring of biologic drugs and vaccines; (3) quality assurance testing of biologic drugs and vaccines; and (4) product release assays for biologic drugs and vaccines. No other commercial use is allowed. “Commercial use” means any and all uses of this product by recipient for monetary or other consideration, including providing a service, information or data to unaffiliated third parties, and resale of this product for any use. Recipient has no right to modify, derivatize, genetically engineer or otherwise create variations of the cells or genes stably transfected within the cells except that recipient may propagate and store the cells for long-term use. In addition, recipient must use luminescent assay reagents purchased from Promega for all luminescence-based assays using this product, or contact Promega to obtain a license for use of this product with reagents other than Promega’s. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING AS TO MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE WITH REGARDS TO THIS PRODUCT. The terms of this agreement shall be governed under the laws of the State of Wisconsin, USA.

Let's find the product that meets your needs.

Talk to a Scientist

scientist-uk-angus

Angus

UK